xpf-001
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2008 (NCT00813670)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- xpf-001
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01090622 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2010 | Radboud University, Xenon Pharmaceuticals Inc. |
| NCT00954356 | Phase 2 | Sep 1, 2009 | Jean Brown Research, Xenon Pharmaceuticals Inc. |
| NCT00813670 | Phase 1 | Nov 1, 2008 | SFBC Anapharm, Xenon Pharmaceuticals Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc. | For profit | 3 | 3 | 2 | 2008 |
| Jean Brown Research | For profit | 1 | 0 | 1 | 2009 |
| Radboud University | Academic/Hospital | 1 | 0 | 1 | 2010 |
| SFBC Anapharm | For profit | 1 | 0 | 1 | 2008 |
4 organizations
Page 1 / 1